Janet Wozniak, MD
Massachusetts General Hospital
11
11
8
N/A
0
7
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+4 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (11)
Showing 10 of 11 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Joseph Biederman, MD
Massachusetts General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Barbara B Biesecker
National Human Genome Research Institute (NHGRI)
Shared therapeutic areas:
Gagan Joshi, MD
Massachusetts General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Antonio Hardan, MD
Stanford University
Shared therapeutic areas:
Flavia Marino
Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)
Shared therapeutic areas:
James McCracken, MD
University of California, Los Angeles
Shared therapeutic areas:
Worked with same sponsors:
Peter J Schmidt, M.D.
National Institute of Mental Health (NIMH)
Shared therapeutic areas:
Robert B Innis, M.D.
National Institute of Mental Health (NIMH)
Shared therapeutic areas:
Forbes D Porter, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (11)
Showing 11 of 11 trials
A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth
Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)
Open-Label Study of N-Acetylcysteine in Children and Adolescents 5-17 With Bipolar Spectrum Disorders
Inositol and Omega-3 Fatty Acids in Pediatric Mania
Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)
Lamotrigine for the Treatment of Mania in Youth Ages 6-17 With Bipolar Disorder
Equetro for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder
Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar Disorder
Invega (Paliperidone) for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolar Disorder
Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents
The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation
All 11 trials loaded